Similar articles

• [Tumor vaccination using monoclonal antibodies].

  Veelken H. Veelken H. Internist (Berl). 2001 Jun;42(6):874-83. doi: 10.1007/s001080170130. Internist (Berl). 2001. PMID: 11449634 Review. German. No abstract available.
• Imatinib mesylate--uncovering a fast track to adaptive immunity.

  Smyth MJ. Smyth MJ. N Engl J Med. 2006 May 25;354(21):2282-4. doi: 10.1056/NEJMcibr061878. N Engl J Med. 2006. PMID: 16723621 No abstract available.
• [Molecular targeted therapy].

  Stenner-Liewen F, Zippelius A, Pestalozzi BC, Knuth A. Stenner-Liewen F, et al. Chirurg. 2006 Dec;77(12):1118-25. doi: 10.1007/s00104-006-1262-8. Chirurg. 2006. PMID: 17109101 Review. German.
• Human Tumor Antigens and Cancer Immunotherapy.

  Vigneron N. Vigneron N. Biomed Res Int. 2015;2015:948501. doi: 10.1155/2015/948501. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161423 Free PMC article. Review.
• Tyrosine kinases as targets for cancer therapy.

  Krause DS, Van Etten RA. Krause DS, et al. N Engl J Med. 2005 Jul 14;353(2):172-87. doi: 10.1056/NEJMra044389. N Engl J Med. 2005. PMID: 16014887 Review. No abstract available.